<DOC>
	<DOCNO>NCT00403611</DOCNO>
	<brief_summary>The primary objective project evaluate efficacy safety praziquantel 60 mg/kg treatment schistosomiasis , compare standard 40 mg/kg therapy representative community highly endemic area schistosomiasis Northeastern Brazil . Cure rate , reduction egg count proportion report side-effects child 10-19 age-range least 100 egg per gram faeces compare regimen , aim evaluate superiority 60 mg/kg 40mg/kg dose currently recommend WHO . Reinfection rate also evaluate aim improve transmission control within local health system , include re-treatment combined auxiliary control measure . Features related clinical , nutritional immunological status patient prior treatment also investigate association outcome praziquantel treatment .</brief_summary>
	<brief_title>Evaluation Praziquantel Dosage Treatment Schistosomiasis Brazil</brief_title>
	<detailed_description>This double blind , randomize , PZQ 40mg/Kg- control clinical trial . Subjects 10-19 year old living community Northeast Brazil identify invited participate study . Well trained field health agent first make sketch map village ( depict location house , main water course , snail habitat water-contact site ) apply household questionnaire obtain personal data resident identify individual 10-19 year age range , well record sanitary standard house water-contact report behaviour described Pieri et al . ( 1998 , Mem . Inst . Oswaldo Cruz , 93 , Suppl 1 : 259-264 ) . Meetings Caric√© Community Association hold order explain inhabitant purpose , objective study , study conduct . Thereafter , resident 10 19 yr age interview home regard fulfilment inclusion/exclusion criterion . Those fulfil criterion agree participate screen phase trial ( sign Screening Informed Consent ) give stool vial ask provide stool sample ( two sample within 5-day interval ) collect home follow day , store heat-proof container take premise Service Reference Schistosomiasis Diagnosis CPqAM promptly prepare examination Kato-Katz method ( Katz et al , 1972 , Rev . Inst . Med . Trop . Sao Paulo , 14 : 397-400 ) aim identify positive case estimate individual egg load . Females childbearing age also ask provide urine sample pregnancy test . Pregnant woman treat Praziquantel weaning , currently recommend Funasa , exclude trial . The 2 stool sample provide individual analyse S. mansoni infection . Two slide prepared stool sample , mean value 4 slide ( measure number eggs/g stool ) calculate . Only harbour least 100 epg able willing follow-up invite participate study . At stage , individual positive diagnosis S. mansoni reason exclude study receive standard treatment schistosomiasis . In enrolment visit subject eligible study , examine physician interviewed ass inclusion/exclusion criterion . Those fulfill criterion invite participate trial go Informed Consent Form procedure ( see detail section 6.14 ) . For accept participate provide write Informed Consent : weight height measure , 5ml venous blood sample collect abdominal ultra-sound exam perform . After procedure , patient assign treatment . Subjects randomly allocate either Group A ( single 40 mg/kg oral dose ) Group B ( single 60 mg/kg oral dose ) , describe section 6.4.3 6.4.4 . Praziquantel tablet provide TDR . During four hour treatment subject observe safety assessment , one day 21 day treatment interview follow symptom related praziquantel side-effects : abdominal pain , diarrhea , vomit , nausea , drowsiness , general malaise , edema , skin rash , urticaria , myalgia , heartburn , fever , dizziness headache ( Guisse et al , 1997 , Am . J. Trop . Med . Hyg. , 56 : 511-514 , 1997 ) . The follow-up visit assess efficacy morbidity 21 day , six month 12 month treatment , subject survey Kato-Katz method ( two stool sample within five-day interval , two slide ) . Weight height measure 6 12 month follow-up . Ultrasound repeat 6 12 month follow-up visit participant present periportal fibrosis liver/spleen enlargement baseline ( D0 ) exam .</detailed_description>
	<mesh_term>Schistosomiasis</mesh_term>
	<mesh_term>Schistosomiasis mansoni</mesh_term>
	<mesh_term>Praziquantel</mesh_term>
	<criteria>Persons 1019 year age harbour least 100 epg able willing followup provide write informed consent participate study Pregnancy lactation Acute chronic severe diseases include hepatosplenic schistosomiasis Use praziquantel last 30 day Known hypersensitivity associate praziquantel Current use medication may affect result present trial , antibiotic corticosteroid , medical condition judgement physician make subject participation impossible .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>